Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Increasing the efficiency of precise gene editing in human cells by manipulating DNA repair

FY 2016-17

Summary
In parallel with a growing understanding of the human genome, our ability to precisely edit our gene code in a deliberate manner is becoming evermore powerful. This ability is largely due to the discovery of CRISPR-Cas9, a molecular complex that specifically cuts DNA at predetermined locations. Occasionally, cells will repair this cut by copying the sequence of another piece of DNA, a mechanism that functions like 'copy and paste'. In fact, a piece of synthetic DNA can be supplied for the cell to use as the template for repair, therefore 'pasting' desired DNA into a predetermined genomic location. This process gives us unprecedented ability to repair errors in gene code that give rise to disease states, ultimately correcting the disease at its source, and therefore curing the affected individual. However, this process is highly inefficient, in that cells' will usually just stitch broken DNA ends back together, rather than using the 'copy and paste' function. Accordingly, my research project is focused on creating molecular tools to enhance the efficiency of this process. My approach involves engineering modified proteins to manipulate cells' DNA repair machinery, in order to encourage cells to 'copy and paste'. These strategies will be tested using a reporter gene that causes cells to fluoresce only if the supplied DNA has been copied into their genome. Therefore, integration efficiency can be quantitatively measured by assessing the proportion of fluorescent cells in a population. The safety of these manipulations to targeted cells will also be closely monitored. Overall, this research will improve the biotechnology we use to edit the human genome, a practice that may one day become commonplace in healthcare.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367310
Name
Seigel Kyle E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Increasing the efficiency of precise gene editing in human cells by manipulating DNA repair
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crispr-Cas9; Dna Repair; Gene Editing; Gene Targeting; Hdr; Nhej; Protein Engineering
Abstract
In parallel with a growing understanding of the human genome, our ability to precisely edit our gene code in a deliberate manner is becoming evermore powerful. This ability is largely due to the discovery of CRISPR-Cas9, a molecular complex that specifically cuts DNA at predetermined locations. Occasionally, cells will repair this cut by copying the sequence of another piece of DNA, a mechanism that functions like 'copy and paste'. In fact, a piece of synthetic DNA can be supplied for the cell to use as the template for repair, therefore 'pasting' desired DNA into a predetermined genomic location. This process gives us unprecedented ability to repair errors in gene code that give rise to disease states, ultimately correcting the disease at its source, and therefore curing the affected individual. However, this process is highly inefficient, in that cells' will usually just stitch broken DNA ends back together, rather than using the 'copy and paste' function. Accordingly, my research project is focused on creating molecular tools to enhance the efficiency of this process. My approach involves engineering modified proteins to manipulate cells' DNA repair machinery, in order to encourage cells to 'copy and paste'. These strategies will be tested using a reporter gene that causes cells to fluoresce only if the supplied DNA has been copied into their genome. Therefore, integration efficiency can be quantitatively measured by assessing the proportion of fluorescent cells in a population. The safety of these manipulations to targeted cells will also be closely monitored. Overall, this research will improve the biotechnology we use to edit the human genome, a practice that may one day become commonplace in healthcare.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Seigel, Kyle E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~